BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 30526305)

  • 1. MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.
    Zhang F; Zakaria SM; Högqvist Tabor V; Singh M; Tronnersjö S; Goodwin J; Selivanova G; Bartek J; Castell A; Larsson LG
    Cell Cycle; 2018; 17(24):2697-2715. PubMed ID: 30526305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc, Cdk2 and cellular senescence: Old players, new game.
    Campaner S; Doni M; Verrecchia A; Fagà G; Bianchi L; Amati B
    Cell Cycle; 2010 Sep; 9(18):3655-61. PubMed ID: 20818171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic ras and p53 cooperate to induce cellular senescence.
    Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
    Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation.
    Jackstadt R; Jung P; Hermeking H
    Cell Death Dis; 2013 Aug; 4(8):e775. PubMed ID: 23949224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.
    Hydbring P; Bahram F; Su Y; Tronnersjö S; Högstrand K; von der Lehr N; Sharifi HR; Lilischkis R; Hein N; Wu S; Vervoorts J; Henriksson M; Grandien A; Lüscher B; Larsson LG
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):58-63. PubMed ID: 19966300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence of human fibroblasts induced by oncogenic Raf.
    Zhu J; Woods D; McMahon M; Bishop JM
    Genes Dev; 1998 Oct; 12(19):2997-3007. PubMed ID: 9765202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a).
    Kosar M; Bartkova J; Hubackova S; Hodny Z; Lukas J; Bartek J
    Cell Cycle; 2011 Feb; 10(3):457-68. PubMed ID: 21248468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal human fibroblasts are resistant to RAS-induced senescence.
    Benanti JA; Galloway DA
    Mol Cell Biol; 2004 Apr; 24(7):2842-52. PubMed ID: 15024073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss.
    Tu Z; Zhuang X; Yao YG; Zhang R
    Mol Cell Biol; 2013 May; 33(9):1819-29. PubMed ID: 23438604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage.
    Sfikas A; Batsi C; Tselikou E; Vartholomatos G; Monokrousos N; Pappas P; Christoforidis S; Tzavaras T; Kanavaros P; Gorgoulis VG; Marcu KB; Kolettas E
    Cell Signal; 2012 Nov; 24(11):2007-23. PubMed ID: 22750558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC synergizes with activated BRAFV600E in mouse lung tumor development by suppressing senescence.
    Tabor V; Bocci M; Alikhani N; Kuiper R; Larsson LG
    Cancer Res; 2014 Aug; 74(16):4222-9. PubMed ID: 24934810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence.
    Kodama R; Kato M; Furuta S; Ueno S; Zhang Y; Matsuno K; Yabe-Nishimura C; Tanaka E; Kamata T
    Genes Cells; 2013 Jan; 18(1):32-41. PubMed ID: 23216904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
    Peeper DS; Shvarts A; Brummelkamp T; Douma S; Koh EY; Daley GQ; Bernards R
    Nat Cell Biol; 2002 Feb; 4(2):148-53. PubMed ID: 11812999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells.
    Zhuang D; Mannava S; Grachtchouk V; Tang WH; Patil S; Wawrzyniak JA; Berman AE; Giordano TJ; Prochownik EV; Soengas MS; Nikiforov MA
    Oncogene; 2008 Nov; 27(52):6623-34. PubMed ID: 18679422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells.
    Kim KS; Kang KW; Seu YB; Baek SH; Kim JR
    Mech Ageing Dev; 2009 Mar; 130(3):179-88. PubMed ID: 19071156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
    Sebastian T; Johnson PF
    Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
    Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
    Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
    Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
    Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of p16INK4a in cell defenses against transformation.
    Drayton S; Brookes S; Rowe J; Peters G
    Cell Cycle; 2004 May; 3(5):611-5. PubMed ID: 15044857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.